Evidence map›Paper›PMID 33144681›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns.

Hannah Stamberger, Trine B Hammer, Elena Gardella, Danique R M Vlaskamp, Birgitte Bertelsen, Simone Mandelstam, Iris de Lange, Jing Zhang, Candace T Myers, Christina Fenger and 75 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. A 350 kbGenes · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Life (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Developmental and epileptic encephalopathies.Nature reviews. Disease primers · 2024
    Review
  14. Article
  15. X-Linked Epilepsies: A Narrative Review.International journal of molecular sciences · 2024
    Review
  16. HeterozygousHeliyon · 2024
    Article
  17. Complexity in Genetic Epilepsies: A Comprehensive Review.International journal of molecular sciences · 2023
    Review
  18. Translational pediatrics · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

85 authors at 20 institutions in 16 countries.

Hannah Stamberger *Epilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia.
Trine B Hammer *Department of Epilepsy Genetics, Danish Epilepsy Centre Filadelfia, Dianalund, Denmark.
Elena GardellaDepartment of Epilepsy Genetics, Danish Epilepsy Centre Filadelfia, Dianalund, Denmark.
Danique R M VlaskampEpilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia.
Birgitte BertelsenCenter for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Simone MandelstamRoyal Children's Hospital, Melbourne, VIC, Australia.
Iris de LangeDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Jing ZhangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Candace T MyersDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.
Christina FengerDepartment of Epilepsy Genetics, Danish Epilepsy Centre Filadelfia, Dianalund, Denmark.
Zaid AfawiTel Aviv University Medical School, Tel Aviv, Israel.
Edith P Almanza FuerteDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.
Danielle M AndradeDivision of Neurology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
Yunus BalcikEpilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, and Center for Personalized Translational Epilepsy Research (CePTER), Goethe-University Frankfurt, Frankfurt am Main, Germany.
Bruria Ben ZeevEdmond and Lily Safra Children's Hospital, Pediatric Neurology Unit, Tel-Hashomer, Israel.
Mark F BennettEpilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia.
Samuel F BerkovicEpilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia.
Bertrand IsidorService de génétique médicale, CHU Nantes, Nantes, France.
Arjan BoumanDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Eva BrilstraDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Øyvind L BuskSection for Medical Genetics, Telemark Hospital, Skien, Norway.
Anita CairnsDepartment of Neurosciences, Queensland Children's Hospital, Brisbane, QLD, Australia.
Roseline CaumesService de Neuropédiatrie, Pôle de Médecine et Spécialités Médicales, CHRU de Lille, Lille, France.
Nicolas ChatronLyon University Hospitals, Departments of Genetics, Lyon, France.
Russell C DaleT.Y. Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Christa de GeusUniversity Medical Centre Groningen, Department of Genetics, Groningen, The Netherlands.
Patrick EderyLyon University Hospitals, Departments of Genetics, Lyon, France.
Deepak GillT.Y. Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Jacob Bie Granild-JensenChild and Youth, Randers Regional Hospital, Randers, Denmark.
Lauren GundersonDepartment of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
Boudewijn GunningStichting Epilepsie Instellingen Nederland, Zwolle, The Netherlands.
Gali HeimerEdmond and Lily Safra Children's Hospital, Pediatric Neurology Unit, Tel-Hashomer, Israel.
Johan R HelleSection for Medical Genetics, Telemark Hospital, Skien, Norway.
Michael S HildebrandEpilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia.
Georgie HollingsworthEpilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia.
Volodymyr KharytonovClinical Hospital "Psychiatry", Kyiv, Ukraine.
Eric W KleeDepartment of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
Bobby P C KoelemanDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
David A KoolenDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.
Christian KorffPediatric Neurology Unit, University Hospitals, Geneva, Switzerland.
Sébastien KüryService de génétique médicale, CHU Nantes, Nantes, France.
Gaetan LescaLyon University Hospitals, Departments of Genetics, Lyon, France.
Dorit LevTel Aviv University, Sackler School of Medicine, Tel Aviv, Israel.
Richard J LeventerRoyal Children's Hospital, Melbourne, VIC, Australia.
Mark T MackayRoyal Children's Hospital, Melbourne, VIC, Australia.
Erica L MackeCenter for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Meriel McEntagartMedical Genetics, St George's University Hospitals NHS FT, Cranmer Tce, London, United Kingdom.
Shekeeb S MohammadT.Y. Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Pauline MoninLyon University Hospitals, Departments of Genetics, Lyon, France.
Martino MontomoliDepartment of Neuroscience, Pharmacology and Child Health, Children's Hospital A. Meyer and University of Florence, Florence, Italy.
Eva MoravaDepartment of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
Sebastien MouttonCPDPN, Pôle mère enfant, Maison de Santé Protestante Bordeaux Bagatelle, Talence, France.
Alison M MuirDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.
Elena ParriniDepartment of Neuroscience, Pharmacology and Child Health, Children's Hospital A. Meyer and University of Florence, Florence, Italy.
Peter ProcopisT.Y. Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Emmanuelle RanzaMedigenome, Swiss Institute of Genomic Medicine, Geneva, Switzerland.
Laura ReedGreat Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Philipp S ReifEpilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, and Center for Personalized Translational Epilepsy Research (CePTER), Goethe-University Frankfurt, Frankfurt am Main, Germany.
Felix RosenowEpilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, University Hospital Frankfurt, and Center for Personalized Translational Epilepsy Research (CePTER), Goethe-University Frankfurt, Frankfurt am Main, Germany.
Massimiliano RossiLyon University Hospitals, Departments of Genetics, Lyon, France.
Lynette G SadleirDepartment of Paediatrics and Child Health, University of Otago Wellington, Wellington, New Zealand.
Tara SadowayDivision of Neurology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
Helenius J SchelhaasStichting Epilepsie Instellingen Nederland, Zwolle, The Netherlands.
Amy L SchneiderEpilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia.
Krati ShahOne Centre of Genetics, Vadodara, India.
Ruth ShalevNeuropaediatric Unit, Shaare Zedek Medical Centre, Hebrew University School of Medicine, Jerusalem, Israel.
Sanjay M SisodiyaDepartment of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom and Chalfont Centre for Epilepsy, Bucks, UK.
Thomas SmolInstitut de Génétique Médicale, Hopital Jeanne de Flandre, Lille University Hospital, Lille, France.
Connie T R M StumpelDepartment of Clinical Genetics and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
Kyra StuurmanDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Joseph D SymondsPaediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.
Frederic Tran Mau-ThemUF Innovation en diagnostic genomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.
Nienke VerbeekDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Judith S VerhoevenAcademic Center for Epileptology, Kempenhaege, Department of Neurology, Heeze, The Netherlands.
Geoffrey WallaceDepartment of Neurosciences, Queensland Children's Hospital, Brisbane, QLD, Australia.
Keren YosovichMolecular Genetics Lab, Wolfson Medical Center, Holon, Israel.
Yuri A ZarateSection of Genetics and Metabolism, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR, USA.
Ayelet ZeremTel Aviv University, Sackler School of Medicine, Tel Aviv, Israel.
Sameer M ZuberiPaediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.
Renzo GuerriniDepartment of Neuroscience, Pharmacology and Child Health, Children's Hospital A. Meyer and University of Florence, Florence, Italy.
Heather C MeffordDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.
Chirag PatelGenetic Health Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
Yue-Hua ZhangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Rikke S Møller *Department of Epilepsy Genetics, Danish Epilepsy Centre Filadelfia, Dianalund, Denmark.
Ingrid E Scheffer *Epilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia. i.scheffer@unimelb.edu.au.ORCID http://orcid.org/0000-0002-2311-2174
Tel Aviv University · ILThe University of Melbourne · AURoyal Children's Hospital · AUThe University of Sydney · AUUniversity Medical Center Utrecht · NLUniversity of Washington · USGoethe University Frankfurt · DEMayo Clinic · USMeyer Children's Hospital · ITUniversité de Lyon · FRCentre National de la Recherche Scientifique · FRCopenhagen University Hospital · DKErasmus MC · NLGénétique Médicale & Génomique Fonctionelle · FRInserm · FRPeking University · CNRoyal Hospital for Children · GBStichting Epilepsie Instellingen Nederland · NLTelemark Hospital · NOUniversity Medical Center Groningen · NL

Funding

A Genomic Approach to EpilepsyR01NS069605 · NINDS · UNIVERSITY OF WASHINGTON · PI MEFFORD, HEATHER C. · 2010 to 2019
$4.9M
NINDS NIH HHS R01 NS069605
6 · The paper itself

Abstract

purposePathogenic variants in the X-linked gene NEXMIF (previously KIAA2022) are associated with intellectual disability (ID), autism spectrum disorder, and epilepsy. We aimed to delineate the female and male phenotypic spectrum of NEXMIF encephalopathy.

methodsThrough an international collaboration, we analyzed the phenotypes and genotypes of 87 patients with NEXMIF encephalopathy.

resultsSixty-three females and 24 males (46 new patients) with NEXMIF encephalopathy were studied, with 30 novel variants. Phenotypic features included developmental delay/ID in 86/87 (99%), seizures in 71/86 (83%) and multiple comorbidities. Generalized seizures predominated including myoclonic seizures and absence seizures (both 46/70, 66%), absence with eyelid myoclonia (17/70, 24%), and atonic seizures (30/70, 43%). Males had more severe developmental impairment; females had epilepsy more frequently, and varied from unaffected to severely affected. All NEXMIF pathogenic variants led to a premature stop codon or were deleterious structural variants. Most arose de novo, although X-linked segregation occurred for both sexes. Somatic mosaicism occurred in two males and a family with suspected parental mosaicism.

conclusionNEXMIF encephalopathy is an X-linked, generalized developmental and epileptic encephalopathy characterized by myoclonic-atonic epilepsy overlapping with eyelid myoclonia with absence. Some patients have developmental encephalopathy without epilepsy. Males have more severe developmental impairment. NEXMIF encephalopathy arises due to loss-of-function variants.

Indexed as

Autism Spectrum DisorderBrain DiseasesEpilepsyFemaleGenes, X-LinkedHumansMaleNerve Tissue ProteinsSeizuresNerve Tissue ProteinsNEXMIF protein, humandevelopmental and epileptic encephalopathyepilepsyintellectual disabilityKIAA2022NEXMIF

Identifiers

PMID33144681
OpenAlexW3095492156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.